New York, June 12, 2026, 10:02 EDT
- Momentus shares fell sharply in early Friday trading after the company priced a new $25 million registered direct stock offering.
- The deal could strengthen cash reserves, but it also adds dilution risk for existing shareholders.
- The next near-term catalyst is the expected June 15 closing of the offering, followed by updates from the Vigoride 7 mission.
Momentus Inc. shares came under pressure Friday after the San Jose-based space infrastructure company announced a new $25 million registered direct offering, a sale of newly issued shares directly to selected investors under an effective registration statement. The company said it agreed to sell 1,851,852 shares of common stock to new and existing long-term institutional investors, with closing expected on or about June 15, subject to customary conditions. Momentus said the net proceeds are intended for working capital and general corporate purposes.
The stock was trading around $13 in early New York trading, down about 20% from Thursday’s $16.30 close, according to live market data and Investing.com’s Friday report on the offering-driven selloff. The drop matters because stock offerings can create dilution, meaning existing shareholders own a smaller percentage of the company after new shares are issued, even if the cash raised improves the balance sheet.
The timing is important. Momentus had already told investors on June 8 that recent capital raises, warrant exercises and use of its at-the-market program had strengthened its balance sheet to roughly $76 million in cash, cash equivalents and short-term investments, while Vigoride 7 had moved into hosted payload mission operations. An at-the-market program allows a company to sell shares into the market over time; it can provide flexible funding but can also weigh on sentiment if investors fear repeated share issuance.
The bull case is that Momentus is no longer trading only on survival risk. In its latest quarterly filing, the company said management believed prior “substantial doubt” about its ability to continue as a going concern no longer existed after financings completed since December 31, 2025. The same filing showed first-quarter service revenue rose to $3.2 million from $0.3 million a year earlier, helped by Vigoride 7 hosted payload services and expanded engineering project work for NASA and DARPA programs. Securities and Exchange Commission
The bear case is that the business remains highly speculative and still loss-making. Momentus reported a first-quarter net loss of $9.48 million, versus a $6.17 million loss a year earlier, and used $5.8 million in operating cash during the quarter. The company also said it may need additional equity or debt financing if circumstances change, and warned that failure to raise capital when needed would hurt its business, results and financial condition.
Friday’s decline also follows a broader surge in investor attention toward space stocks around SpaceX’s record IPO. Reuters reported that SpaceX priced a $75 billion IPO at $135 a share on June 11, valuing the company at about $1.77 trillion, while earlier Reuters coverage noted that enthusiasm around the listing had lifted interest in publicly traded space companies. That backdrop may have helped momentum traders notice smaller space names such as Momentus, but Friday’s offering reminded investors that balance-sheet improvement can come at the cost of dilution.
The next major catalyst is whether the $25 million registered direct offering closes as expected around June 15 and whether the company files the prospectus supplement with terms that investors view as manageable. After that, the operational catalyst is proof that Vigoride 7 can keep progressing through its multi-month hosted payload mission, because stronger mission execution could support future government and commercial work. Momentus said Vigoride 7 launched to low Earth orbit on March 30 with 10 payloads, including payloads connected to DARPA, SpaceWERX, the U.S. Air Force Research Laboratory, NASA and commercial customers.
Based on verified facts today, Momentus stock looks risky rather than clearly attractive or fairly valued. The improved cash position and institutional funding support the bull argument, but the stock’s valuation is difficult to anchor because the company is not profitable, the share count has changed rapidly through offerings and warrant activity, and further capital needs remain a stated risk. For investors, the key question is whether new cash can translate into mission execution and repeatable revenue faster than dilution absorbs the upside.
